2661062
SCDGP · Clinical drug group packinfluenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Victoria/1/2020 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Inhalant Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Victoria/1/2020 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Inhalant Product?
influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Victoria/1/2020 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Inhalant Product is coded as 2661062 in RxNorm.
What is RxNorm code 2661062?
2661062 is the RxNorm identifier for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Victoria/1/2020 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Inhalant Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2661062?
2661062 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2661062?
2661062 maps to UMLS C5844868.